294 studies found for:    opioid receptors
Show Display Options
Rank Status Study
1 Completed
Has Results
Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia
Conditions: Labor Pain;   Post-cesarean Delivery
Intervention: Procedure: Blood Draw
2 Completed [11C]Carfentanil PET Study of GSK1521498
Condition: Obesity
Interventions: Drug: Part A Assessing GSK1521498;   Drug: Part B Assessing GSK1521498;   Drug: Part C Assessing Naltrexone
3 Terminated A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)
Conditions: Bipolar Disorder;   Depression
Intervention: Drug: PF-04455242
4 Completed A Study of Brain Receptor Occupancy in Healthy Subjects
Condition: Alcohol Dependence
Intervention: Drug: opioid receptor kappa antagonist
5 Recruiting μ-opioid Receptor Polymorphism and Opioid Analgesia
Condition: Pharmacogenetic and Duration of Labor Fentanyl Analgesia.
Intervention: Drug: Fentanyl
6 Unknown  Effects of Smoking on Opioid Receptor Binding: A PET Study
Condition: Substance-related Discorder
Interventions: Drug: Nicotine;   Drug: Carfentanil
7 Completed To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers
Condition: Alcoholism
Interventions: Drug: GSK1521498;   Drug: Naltrexone (NTX);   Drug: Placebo
8 Recruiting Mu Opioid Receptor Genes, Remifentanil, and Pain Sensitivity
Conditions: Polymorphism-Genetic;   Alcohol Drinking;   Alcohol-Related Disorders;   Alcoholism;   Allelic Frequencies of Genetic Markers
Interventions: Genetic: OPRM1 AA118;   Drug: Morphine;   Drug: Placebo;   Genetic: OPRM1 GX118
9 Not yet recruiting Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin Addicts
Condition: Heroin Addiction
Intervention:
10 Not yet recruiting Endogenous Opioid Activity and Affective State in Insulin Resistant Women
Conditions: Depression;   Insulin Resistance;   Metabolic Syndrome
Intervention: Drug: Metformin
11 Suspended Opioid Receptors Influence Ischemia-Reperfusion Injury
Condition: Ischemia-Reperfusion Injury
Interventions: Drug: morphine;   Drug: naloxone;   Drug: Technetium-TC99m-labeled Annexin A5;   Procedure: forearm ischemic exercise;   Procedure: ten minute forearm ischemia
12 Terminated Effects of Nicotine on Brain Opioid Receptors
Condition: Nicotine Dependence
Intervention: Drug: Nicotine
13 Unknown  Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section
Condition: Postoperative Pain
Intervention: Drug: Morphine
14 Completed Genetic Determinants of Opioids Analgesia
Condition: Nephrolithiasis
Intervention: Drug: Alfentanil
15 Recruiting Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
Condition: Opioid Related Disorder
Interventions: Drug: RBP-6000;   Drug: Subutex
16 Unknown  Pain and Schizophrenia
Conditions: Pain;   Schizophrenia
Intervention:
17 Recruiting Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism
Condition: Alcohol Dependence
Interventions: Drug: Drug;   Drug: Placebo
18 Completed Effects of Yohimbine and Naltrexone on Sexual Function
Condition: Erectile Dysfunction
Intervention: Drug: Naltrexone HCL/ Yohimbine HCL
19 Completed Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Condition: Opioid Induced Constipation
Interventions: Drug: Placebo;   Drug: ADL5945 0.1 mg;   Drug: ADL5945 0.25 mg
20 Completed Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Condition: Constipation
Interventions: Drug: Placebo;   Drug: ADL5945 0.25 mg

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years